About potassium sodium hydrogen citrate
Urinary alkalinising agent
Used for
- Prevention and treatment of uric acid kidney stones
- Alkalinising urine in selected kidney stone conditions
Usual adult dose
Typically 2.5–5 g granules dissolved in water, three times daily; dose is adjusted to urine pH.
Usual dose in children
Not routinely used in children; specialist dosing depends on age and urine tests.
Common side effects
- Stomach discomfort, nausea, or diarrhoea
- Raised blood potassium or sodium
- Metabolic alkalosis
Important warnings
- Requires monitoring of urine pH and blood electrolytes.
- Avoid or use cautiously with impaired kidney function or high blood potassium.
- May be unsuitable with heart failure, high blood pressure, or sodium restriction.
Pregnancy
Use only when needed under medical supervision; pregnancy safety information is limited.
Breastfeeding
Use under medical supervision; information during breastfeeding is limited.
Interactions
- Potassium-sparing diuretics, ACE inhibitors, or ARBs may raise blood potassium.
- Antacids or other alkalinisers can increase alkalosis risk.
- Alkaline urine can alter the effects or removal of some medicines, including methenamine.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.